Li Liu

QuantumPharm, Inc. operates as a holding company with interests in drug research and development services. It engages in the business relating to drug discovery solutions including one-stop drug discovery solutions and automated chemical synthesis services and intelligent automation services. The company was founded by Lai Li Ppeng, Ma Jian and Wen Shu Hao in 2015 and is headquartered in Shenzhen, China.

Edge Medical Robotics Co., Ltd. engages in the design, development, manufacture, and commercialization of surgical robots. Its products include multi-port endoscopic surgical robot, single-port endoscopic surgical robot, bronchoscopy robot, and minimally invasive surgical instruments. The company was founded by Jian Chen Wang and Yuan Qian Gao on May 4, 2017 and is headquartered in Shenzhen, China.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong.

Hupu Sports (Shanghai) Media Holding Co., Ltd. operates an online sports information platform. It provides sports news including football and basketball games, sports forums, videos, and event information. It also involves in the sale of sports products such as shoes, sports equipment, and sports wear. The company was founded by Hang Cheng in 2004 and is headquartered in Shanghai, China.

Refuge Biotechnologies, Inc. develops therapeutic cells. It is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decisions inside the patient’s body. The firms programs include RB-1916, RB-H21 and RB-M1. The company was founded by Stanley Qi, David R. Parkinson and Bing C. Wang and is headquartered in Menlo Park, CA.

NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA.

Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China.

Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA.

Wuhan Neurophth Biotechnology Co., Ltd. is a leading in-vivo gene therapy company for ophthalmic diseases based in Wuhan, China. The Chinese company's core product, nr082 (nfs-01), is designed to treat ND4-mediated Leber's hereditary optic neuropathy (ND4-LHON) and has been granted orphan drug designation (ODD) by the FDA and EMA. It is the first Chinese gene therapy new drug that has been granted IND approval for clinical trials by the Chinese National Medical Products Administration (NMPA) and the FDA. The company's pipeline also includes ND1-mediated LHON, autosomal dominant optic atrophy, optic nerve protection, vascular retinopathy, and other preclinical candidates. The company was founded in 2016 by Bin Li, Su Xiao, Dabo Cai, and Bin Li has been the CEO since then.

Crystal Pharmatech Co., Ltd. engages in the provision of materials science and engineering services for drug development. It provides drug crystal research and development, pharmaceutical drug technology research, formulation prescription technology development, crystal form study, chemical process development, formulation development, medicine analysis, solid-state detection, and product quality research services. The company was founded by Min Hua Chen, Yan Feng Zhang, Jia Lin Wang, Robert Wenslow and Su Ling Zhang on July 21, 2010 and is headquartered in Suzhou, China.

Distinct Healthcare Holdings Ltd. provides healthcare service. It services include in healthcare service institutions comprise hospitals, primary healthcare service institutions (such as community health service centers, township health service centers, village clinics, outpatient departments and clinics) and specialized public healthcare service institutions. The company was founded by Zhu Yan, Shi YI and Wang Zhiyuan in 2012 and is headquartered in Shenzhen, China.

Sandia National Laboratories develops science based technologies. The company provides research services in nuclear weapons, energy and infrastructure assurance, nonproliferation, and defense systems. The company was founded in 1948 and is headquartered in Albuquerque, NM.

Tau Ventures LLC (Tau Ventures) is a venture capital firm founded in 2018 by Amit Garg and Sanjay K. Rao. The firm is headquartered in Palo Alto, California.

Ibis Therapeutics LLC is a pharmaceutical company that manufactures therapeutics. The company is based in Tampa, FL. The company was founded by William A. Glauser, Sam Shrivastava. Sam Shrivastava has been the CEO since incorporation.

IOI Partners LLC provides business advisory services. The company is based in Zionsville, IN. The company was founded by Scott Atkin, Paul Glyer.

Jefferies Hong Kong Ltd. is a securities brokerage firm headquartered in Hong Kong. The firm is a subsidiary of Jefferies Group LLC, which is owned by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. Jefferies Hong Kong is a client-focused full-service sales, trading and capital markets platform across all equity and fixed income securities. They provide an array of trading and execution services for their clients.

Beijing Yijiupi E-Commerce Co., Ltd. operates an Internet platform for sale of alcoholic beverages, food, and other fast-moving consumer goods. The company was founded by Sheng Qiang Chen, Shi Tao, and Zhao Cheng Wang on September 10, 2014 and is headquartered in Beijing, China.

Beijing Yuanxin Technology Group Co., Ltd. Operates as a healthcare technology company. It provides out-of-hospital comprehensive patient services, provider-enabling services and innovative healthcare services. The company was founded by He Tao on 20 March, 2015 and is headquartered in Beijing, China.

Tencent Investment provides investment services. Rui Hao has been the CEO of the Chinese company since 2013.

Part of Tencent Holdings Ltd., Shenzhen Litong Industry Investment Fund Ltd. is an investment holding company. The company is based in Shenzhen, China. The Chinese company was founded in 2013. The CEO is Rui Hao.

Beijing Nuoxin Chuanglian Technology Co. Ltd. operates mobile applications for medical treatments. It provides customized digital marketing services related to medical industries. The company was founded by Ruan Wei on June 18, 2014 and is headquartered in Beijing, China.

Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin.